Literature DB >> 17327401

Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin.

Claudia Waskow1, Susanne Bartels, Susan M Schlenner, Celine Costa, Hans-Reimer Rodewald.   

Abstract

Cutaneous mast cells have important pathogenic roles in skin inflammation, but the signals regulating mast-cell numbers in healthy and inflamed skin are not fully understood. Mast-cell development depends on the receptor tyrosine kinase Kit as shown by a greater than 95% reduction of mast-cell numbers in hypomorphic (Kit(W/Wv)) mutant mice that are widely used as a mast-cell deficiency model. Mast-cell numbers are normally very low in Kit(W/Wv) mice, but numbers can strongly increase under inflammatory conditions. It remains elusive whether this inflammation-driven mast-cell accumulation is mediated by signals transmitted via the Kit(Wv) receptor or by other, Kit-independent stimuli. We show here, using viable Kit- null mice (Kit(W/W)), that Kit is essential for mast-cell accumulation in phorbol-12-myristate-13-acetate (PMA)-treated, chronically inflamed skin. This increase in mast- cell numbers is strongly attenuated in Kit(W/Wv) mice lacking mature lymphocytes (T, B, and natural killer [NK] cells). These data, together with reconstitution experiments, point at a role for lymphocytes in the regulation of mast-cell compartments under limiting Kit signaling. We conclude that inflammation-induced cutaneous mast-cell accumulation is dependent on Kit signaling strength, and, under limiting Kit signals, on cells of the adaptive immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327401     DOI: 10.1182/blood-2006-08-039131

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

2.  Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

Authors:  Sebastian Willenborg; Beate Eckes; Jürgen Brinckmann; Thomas Krieg; Ari Waisman; Karin Hartmann; Axel Roers; Sabine A Eming
Journal:  J Invest Dermatol       Date:  2014-01-09       Impact factor: 8.551

3.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

4.  Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.

Authors:  Ravi P Sahu; Amal A Kozman; Yongxue Yao; Sonia C DaSilva; Samin Rezania; Kellie C Martel; Simon J Warren; Jeffrey B Travers; Raymond L Konger
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

5.  Partial protection against Helicobacter pylori in the absence of mast cells in mice.

Authors:  Hua Ding; John G Nedrud; Barry Wershil; Raymond W Redline; Thomas G Blanchard; Steven J Czinn
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

6.  Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.

Authors:  Ravi P Sahu; Samin Rezania; Jesus A Ocana; Sonia C DaSilva-Arnold; Joshua R Bradish; Justin D Richey; Simon J Warren; Badri Rashid; Jeffrey B Travers; Raymond L Konger
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.